Recurrent acute stent thrombosis and myocardial infarction in a young patient.

Sharolyn Cook, John Evans, Stephen Dixon


Myocardial infarctionin patients under the age of 45 is considered rare occurring in approximately 6-10% of the general population. In many cases, premature coronary atherosclerosis plays an important causative role, however about 20% of young adult coronary thrombosis can be attributed to hypercoagulability. In this article, we present a 43 year old patient with recurrent coronary thrombosis. While an initial presentation of acute myocardial infarction appeared driven by common re-thrombosis and acute stent thrombosis revealed a hypercoagulable state. This case highlights challenges in management of acute myocardial infarction and hypercoagulable states. It emphasizes the vigilance that must be exercised in generating differential diagnoses for coronary thrombosis.


coronary thrombosis, recurrent stent thrombosis, hypercoagulable state, myocardial infarction, young patients with myocardial infarction

Full Text:




Hong MK, Cho SY, Hong BK, et al. Acute myocardial infarction in the young adults. Yonsei Medical Journal. 1994;35:184–189

Jalowiec DA, Hill, JA. Myocardial infarction in the young and in women. Cardiovascular Clinics. 1989;20:197–206.

Choudhury L, Marsh JD. Myocardial Infarction in Young Patients. American Journal of Medicine. 1999;107(3):254-261.

Lane DA, Mannuci PM, Bauer KA, et al. Inherited Thrombophilia: Part 1. Article in Thrombosis and Haemostasis. 1996;76(5):651-662.

Nachman RL, Silverstein R. Hypercoagulable States. Annals of Internal Medicine. 1993;119:819-827.

Bick RL, Kaplan H. Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Causes of Thrombosis. Medical Clinics of North America. 1998;82(3):409-458.

Inbal, A., Freimark, D., Modan, B., Chetrit, A., Matetzky, S., Rosenberg, N., Dardik, R., Baron, Z., & Seligsohn, U. Synergistic Effects of Prothrombotic Polymorphisms and Atherogenic Factors on the Risk of Myocardial Infarction in Young Males. Blood. 1999;93(7):2186-2190.

Batalla A, Reguero JR, Cubero GI, Coto E. Prothrombotic Genetic Risk Factors and Myocardial Infarction at Young Age. Blood. 1999;94:3959-3960.

Kannel WB, Abbott RD (1984) Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 311:1144–1147.

Levy PJ, Gonzalez FM, Rush DS, Haynes JL. Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis. J Am Coll Surg. 1994 Mar;178(3):266-70.

Brey RL, Abbott RD, Sharp DS, Ross GW, Curb JD, Stallworth CL, Kittner SJ. Beta-2-glycoprotein 1-dependent (B2GP1-dep) Anticardiolipin Antibodies (aCL) Are An Independent Risk Factor for Ischemic Stroke in the Honolulu Heart Cohort. Stroke. 2001;32:1701-1706.

Doggen CJM, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors. Increased risk of myocardial infarction associated with factor V Leiden or prothrombin. Circulation. 1998;97:1037.

Ho YL, Chen MF, Wu CC, et al. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Cardiology.1996;87:354–357.

Takeuchi S, Obayashi T, Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart. 1998;79:96–98.

Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. The Lancet. 2010;376(9751):1498-1509.

Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Huges GRV. The management of Thrombosis in the Antiphospholipid-Antibody Syndrome. The New England Journal of Medicine. 1995;332(15):993-997.

Cohen H, Hunt BJ, Efthymiou M, Arachchillage DRJ, Mackie IJ, et al. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. Lancet Haematology.2016;3:426-436.

Koniari I, Siminelakis SN, Baikoussis NG, et al. Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. Journal of Cardiothoracic Surgery. 2010;5(101).


  • There are currently no refbacks.